6CPN image
Deposition Date 2018-03-13
Release Date 2018-06-06
Last Version Date 2024-10-30
Entry Detail
PDB ID:
6CPN
Keywords:
Title:
Crystal structure of DR11 presenting the RQ13 peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
HIV-1 M:B_HXB2R (Taxon ID: 11706)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 31 1 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DR alpha chain
Gene (Uniprot):HLA-DRA
Chain IDs:A
Chain Length:182
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DRB1-11 beta chain
Chain IDs:B
Chain Length:190
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Gag polyprotein
Chain IDs:C
Chain Length:13
Number of Molecules:1
Biological Source:HIV-1 M:B_HXB2R
Primary Citation
CD4+T cell-mediated HLA class II cross-restriction in HIV controllers.
Sci Immunol 3 ? ? (2018)
PMID: 29884618 DOI: 10.1126/sciimmunol.aat0687

Abstact

Rare individuals, termed HIV controllers, spontaneously control HIV infection by mounting efficient T cell responses against the virus. Protective CD4+ T cell responses from HIV controllers involve high-affinity public T cell receptors (TCRs) recognizing an immunodominant capsid epitope (Gag293) presented by a remarkably broad array of human leukocyte antigen (HLA) class II molecules. Here, we determine the structures of a prototypical public TCR bound to HLA-DR1, HLA-DR11, and HLA-DR15 molecules presenting the Gag293 epitope. TCR recognition was driven by contacts with the Gag293 epitope, a feature that underpinned the extensive HLA cross-restriction. These high-affinity TCRs promoted mature immunological synapse formation and cytotoxic capacity in both CD4+ and CD8+ T cells. The public TCRs suppressed HIV replication in multiple genetic backgrounds ex vivo, emphasizing the functional advantage conferred by broad HLA class II cross-restriction.

Legend

Protein

Chemical

Disease

Primary Citation of related structures